Organization
Centre Hospitalier Universitaire de Besancon
25 clinical trials
Clinical trial
Combination Chemotherapy (Methotrexate, L-asparaginase, Idarubicin and Dexamethasone) in Patients With Newly Diagnosed Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)Status: Active (not recruiting), Estimated PCD: 2023-02-13
Clinical trial
Ezabenlimab (BI 754091) and mDCF (Docetaxel, Cisplatin and 5-fluorouracil) Followed by Chemoradiotherapy in Patients With Stage III Squamous Cell Anal Carcinoma. A Phase II StudyStatus: Active (not recruiting), Estimated PCD: 2024-07-05
Clinical trial
Spartalizumab, mDCF (Docetaxel, Cisplatin and 5-fluorouracil) and Radiotherapy in Patients With Metastatic Squamous Cell Anal Carcinoma. A Phase IIA StudyStatus: Recruiting, Estimated PCD: 2025-06-01
Clinical trial
Phase I-II Study Chemoradiation in Elderly Patients With Oesophagus CancerStatus: Recruiting, Estimated PCD: 2028-11-16
Clinical trial
Chemotherapy Intensification in Patients With High Lactate Dehydrogenase Values and Soluble Syndecan-1 LevelsStatus: Active (not recruiting), Estimated PCD: 2024-12-01
Clinical trial
Evaluation of a New Multiplex Quantitative PCR Technique for the Diagnosis of EchinococcosisStatus: Recruiting, Estimated PCD: 2026-10-01
Clinical trial
Intraoperative Indocyanine Green Fluorescence Angiography in Colorectal Surgery to Prevent Anastomotic Leakage: a Single-blind Phase III Multicenter Randomized Controlled Trial (Intergroup FRENCH-GRECCAR Trial)Status: Recruiting, Estimated PCD: 2025-10-31
Clinical trial
Anticancer Therapeutic Vaccination Using Telomerase-derived Universal Cancer Peptides in GlioblastomaStatus: Active (not recruiting), Estimated PCD: 2023-12-01
Clinical trial
Normoxemic Versus Hyperoxemic Extracorporeal Oxygenation : Impact on Organ Dysfunction in Patients Supported by Veino-arterial ECMO for Cardiogenic ShockStatus: Recruiting, Estimated PCD: 2024-02-09
Clinical trial
Induction Regorafenib in Combination With Metronomic Cyclophosphamide, Capecitabine, and Low-dose Aspirin Followed by Chemotherapy in Second Line Metastatic Colorectal Cancer Carcinoma An Open-label Randomized Phase II-III StudyStatus: Recruiting, Estimated PCD: 2029-11-01
Clinical trial
Regorafenib in Combination With Metronomic Cyclophosphamide, Capecitabine, and Low-dose Aspirin in Metastatic Colorectal Cancer Carcinoma An Open-label Phase IIStatus: Completed, Estimated PCD: 2023-12-13
Clinical trial
Evaluation of the Interest to Combine a CD4 Th1-inducer Cancer Vaccine Derived From Telomerase and Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma: a Proof of Concept Randomized Phase II Study (TERTIO - Prodige 82)Status: Recruiting, Estimated PCD: 2025-04-30
Clinical trial
A Multicenter, Double-blind, Placebo-controlled Randomized Clinical Trial Comparing Two Strategies of Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Severe Cirrhotic Patients With Ascites : Using or Not Using RifaximinStatus: Completed, Estimated PCD: 2022-06-05
Clinical trial
Impact of Regorafenib in Combination With Multimodal Metronomic Chemotherapy on Progression-free Survival Compared With Standard Regorafenib for the Treatment of Chemo-resistant Metastatic Colorectal CancersStatus: Not yet recruiting, Estimated PCD: 2027-09-01
Clinical trial
Benefit of Cryopreserved Human Amniotic Membrane (hAM) on Oral Mucosal Healing Among Patients With Stage II Maxillomandibular Osteonecrosis Induced by Antiresorptive and/or Anti-angiogenic Therapies: a Phase II Randomized TrialStatus: Recruiting, Estimated PCD: 2025-09-01
Clinical trial
Clinical Effectiveness of Hypertonic Sodium Lactate Infusion for Intraoperative Brain Relaxation in Patients Undergoing Scheduled Craniotomy for Supratentorial Brain Tumor Resection: Study Protocol of a Single Center Double-blind Randomized Controlled Phase II Pilot TrialStatus: Completed, Estimated PCD: 2023-05-31
Clinical trial
Evaluation of Cirrhotic Cardiomyopathy by Cardiac MRI in Patients Waiting for Liver Transplant. A Multicenter Prospective Pilot Study. (CARDIO-FIBROCIR)Status: Not yet recruiting, Estimated PCD: 2025-03-31
Clinical trial
Anticancer Therapeutic Vaccination Using Telomerase-derives Universal Cancer Peptides in Metastatic Non Small Cell Lung Cancer : A Phase I/II StudyStatus: Active (not recruiting), Estimated PCD: 2022-08-30
Clinical trial
A Phase II Study Evaluating the Interest to Combine UCPVax a CD4 TH1-inducer Cancer Vaccine and Atezolizumab for the Treatment of Human PapillomaVirus Positive CancersStatus: Active (not recruiting), Estimated PCD: 2024-09-01
Clinical trial
Activity and Tolerability of Maintenance Avelumab Immunotherapy After First Line Polychemotherapy Including Platinum in Patients With Locally Advanced or Metastatic Squamous Cell Penile CarcinomaStatus: Recruiting, Estimated PCD: 2024-09-22
Clinical trial
Non-invasive Tools to Better Diagnose Invasive Aspergillosis Infections in ICU Patients With COVID-19 and Other Non-immunosuppressive Conditions.Status: Recruiting, Estimated PCD: 2024-03-01
Clinical trial
TAP Block Versus Local Anesthesia Infiltration at Wound Site for Postoperative Pain Relief After Laparoscopic Appendicectomy in ChildrenStatus: , Estimated PCD: 2023-12-25
Clinical trial
Evaluation of UCPVax Plus Nivolumab as Second Line Therapy in Advanced Non Small Cell Lung : a Randomized Non Comparative Phase II TrialStatus: Active (not recruiting), Estimated PCD: 2023-09-01
Clinical trial
Hypersensitivity Pneumonitis of Domestic Origin: Investigation of the Microorganisms Involved and Improvement of Serological Diagnosis.Status: Not yet recruiting, Estimated PCD: 2026-03-01
Clinical trial
Evaluation of Polychemotherapy With XELOXIRI-3 in Elderly or Frail Patients With Advanced Pancreatic Adenocarcinoma (ALIX)Status: Terminated, Estimated PCD: 2023-08-01